In our recent study, we showed that the pro-inflammatory function of CD4+ T cells was associated with the glutamine metabolic pathway and that inhibition of glutaminase 1 alleviated SS-like symptoms in NOD/ShiLtj mice (Fu et al., 2022). Here, CD4 is linked to synovial sarcoma.